Please login to the form below

Not currently logged in

The most viewed healthcare terms

The terms and definitions that have received the most views since we launched the PMliVE Glossary.

  • Cost utility analysis (health economics)
    In healthcare economics a form of cost-effectiveness analysis in which the results are expressed in terms of cost per quality adjusted life year (QALY) gained
  • Business to consumer (B2C)
    Relating to the sale of a product for personal consumption. The buyer may be an individual, family or other group, buying to use the product themselves, or for end use by another individual
  • Healthy years equivalent (HYE)
    The conjectured number of years lived in perfect health that could be regarded as equivalent to the precise number of years spent in a specific imperfect state of health .
  • Post-testing
    The evaluation of the effectiveness and impact of an advertising campaign either during or after the campaign's run
  • e-Commerce
    Any business transaction that takes place via electronic platforms 
  • Majority fallacy
    The erroneous belief that directing a new product to an entire market, or the largest section within that market, will be the most profitable because of the large amount of potential customers. Competition is usually most competitive in this segment
  • Four Ms
    Money, material, machine and manpower – the traditional framework for viewing the resources available to a business, which can be useful when designing a business plan
  • Offensive marketing
    An openly competitive marketing strategy involving one company exposing and attacking the weaker points of another company in order to take market share directly away from the competition
  • Off-label use
    A healthcare professional approving a drug for a condition for which it is not approved by the necessary regulatory body
  • Cost-effectiveness (in media/advertising)
    A measure of media effectiveness based on a comparison of potential or actual audience and the cost for placement, usually expressed as cost-per-thousand persons viewing
  • Brand
    The set of physical attributes of a product or service, together with the beliefs and expectations surrounding it – a unique combination which the name or logo of the product or service should evoke in the mind of the audience 
  • Open-label trial
    A clinical trial where the drug or vaccine being tested is known to both researchers and participants. This contrasts with a single-blind trial, where the patient is unaware of the drug or vaccine, and a double-blind trial, where both researchers and patients are unaware.
  • United States adopted name (USAN)
    A designation for any compound used as a drug that is not protected as an intellectual property. This name is negotiated by the compound's manufacturers as well as a council sponsored jointly by the American Medical Association, American Pharmaceutical Association, and United States Pharmacopeial Convention
  • Boston matrix
    A product portfolio evaluation tool developed by the Boston Consulting Group, the matrix categorises products into one of four classifications based on market growth and market share. 

    The four classifications are:

    Cash cow – low growth, high market share
    Star – high growth, high market share
    Problem child – high growth, low market share
    Dog – low growth, low market share
  • Price taker
    A producer who has no power to influence prices
  • Key opinion leader (KOL)
    Consultant or acknowledged expert whose early and enthusiastic endorsement of a new treatment or treatment protocol is sought because they are respected and influential in that market
  • Pharmaceutical Pricing Regulation Scheme (PPRS)
    The prices of branded medicines in the NHS are controlled by the Pharmaceutical Price Regulation Scheme (PPRS) negotiated by the UK government with the Association of the British Pharmaceutical Industry (ABPI), as the representative body for those companies supplying the NHS with medicines
  • Infiltration marketing
    A marketing strategy aimed at infiltrating consumers at a local level, targeting the communities and communications of potential trend setters. This can include a marketer’s use of social media or online forums to engage with customers about a product or service
  • Placebo effect
    The phenomenon where a person receiving an inactive substance undergoes a physical or emotional change that is not the result of any special property in the substance. These changes can often reflect the expecations of both the participant and the person administering the inactive substance, with a belief that the treatment is effective having a beneficial effect.
  • Bias
    When a point of view prevents impartial judgment on issues relating to the subject of that point of view. In clinical studies, bias is controlled by blinding and randomisation

Featured jobs

Subscribe to our email news alerts


Add my company
Red Door Communications

Red Door Communications (RDC) is the health and wellbeing communications consultancy that lives and breathes originality and is built on...